SK pharmteco
William DuBay has extensive experience in research and development within the pharmaceutical industry. William started their career in 2000 as a Project Manager at Catalytica Pharmaceuticals. In 2002, they joined DSM as an R&D Manager, specializing in custom manufacturing fermentation. In 2006, they moved to AMPAC Fine Chemicals and served as the VP of Research & Development until 2019. Currently, they hold the position of Vice President of Global Research and Development at SK pharmteco.
William DuBay completed their education with a PhD in Organic Chemistry from the University of South Carolina in 1994. William then pursued post doctorate studies at Indiana University Bloomington, focusing on Organic Chemistry from 1994 to 1995.
SK pharmteco
Headquartered in Rancho Cordova, California, SK pharmteco is a global contract development and manufacturing organization specializing in the production of active pharmaceutical ingredients (APIs), advanced intermediates, and cell and gene therapy for the pharmaceutical industry. Built on 80 years of experience, our global operations have the capability and capacity to support client needs from development through commercial production. SK pharmteco is owned by SK Inc., the strategic investment arm of South Korea’s SK Group.